Mepolizumab | All | Licensing, EU CTD Dossiers, Formulation Suppliers | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Mepolizumab
FDF Dossiers

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Mepolizumab

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

1 API Suppliers, 1 Listed Suppliers

1 API Suppliers
1 Listed Suppliers

DEVELOPMENTS

13 Drugs in Development

13 Drugs in Development

FINISHED DOSAGE FORMULATIONS

18 FDF Dossiers, 2 FDA Orange Book, 5 Europe, 3 Canada, 8 Australia

18 FDF Dossiers
2 FDA Orange Book
5 Europe
3 Canada
8 Australia

RELATED EXCIPIENT COMPANIES

1 Jai Radhe Sales, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 3 Actylis, 1 BASF, 4 Gangwal Chemicals, 1 Nanjing Bold Chemical, 6 Seppic

1 Jai Radhe Sales
1 Nanjing Well Pharmaceutical
1 Pfanstiehl
3 Actylis
1 BASF
4 Gangwal Chemicals
1 Nanjing Bold Chemical
6 Seppic

EXCIPIENTS BY APPLICATIONS

10 Solubilizers, 6 Parenteral, 4 Thickeners and Stabilizers, 3 Topical, 3 Emulsifying Agents, 2 Film Formers & Plasticizers, 2 Taste Masking, 2 Surfactant & Foaming Agents, 2 Coating Systems & Additives, 1 Co-Processed Excipients, 1 Direct Compression, 1 Rheology Modifiers, 1 API Stability Enhancers

10 Solubilizers
6 Parenteral
4 Thickeners and Stabilizers
3 Topical
3 Emulsifying Agents
2 Film Formers & Plasticizers
2 Taste Masking
2 Surfactant & Foaming Agents
2 Coating Systems & Additives
1 Co-Processed Excipients
1 Direct Compression
1 Rheology Modifiers
1 API Stability Enhancers

DIGITAL CONTENT

4 DATA COMPILATION #PharmaFlow, 1 STOCK RECAP #PipelineProspector, 77 NEWS #PharmaBuzz

4 DATA COMPILATION #PharmaFlow
1 STOCK RECAP #PipelineProspector
77 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 4 Finished Drug Prices, 8 Annual Reports

1 US Medicaid Prescriptions
4 Finished Drug Prices
8 Annual Reports

MARKET PLACE

1 APIs, 1 FDF Dossiers

1 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 Health Canada Patents

1 Health Canada Patents

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

18 All

01 17GSK

02 1GlaxoSmithKline Trading

filter Dosage Reset all filters

18 All

01 1Dry Sub

02 1INJECTABLE;SUBCUTANEOUS

03 1INJECTABLE;SUBCUTANEOUS LYOPHILIZED POWER

04 3Inj L?s

05 1POWDER FOR SOLUTION FOR INJECTION

06 3SOLUTION

07 8Blank

filter Regulatory Info Reset all filters

18 All

01 3Prescription

02 15Blank

filter Brand Name Reset all filters

18 All

01 5NUCALA

02 13Nucala

filter Country Reset all filters

18 All

01 8Australia

02 3Canada

03 1Sweden

04 4Switzerland

05 2USA

List of Suppliers

Product Main Page

01

GSK

2024 ACI Convention

Not Confirmed

GSK

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : USA

MEPOLIZUMAB

Brand Name : NUCALA

Dosage Form : INJECTABLE;SUBCUTANEOUS LYOPHILIZED POWER

Dosage Strength : 100MG

Packaging :

Approval Date :

Application Number : 125526

Regulatory Info :

Registration Country : USA

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

GSK

2024 ACI Convention

Not Confirmed

GSK

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : USA

MEPOLIZUMAB

Brand Name : NUCALA

Dosage Form : INJECTABLE;SUBCUTANEOUS

Dosage Strength : 100MG/ML

Packaging :

Approval Date :

Application Number : 761122

Regulatory Info :

Registration Country : USA

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

GSK

2024 ACI Convention

Not Confirmed

GSK

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Switzerland

Mepolizumabum

Brand Name : Nucala

Dosage Form : Dry Sub

Dosage Strength : 100mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

GSK

2024 ACI Convention

Not Confirmed

GSK

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Switzerland

Mepolizumabum

Brand Name : Nucala

Dosage Form : Inj L?s

Dosage Strength : 100mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

GSK

2024 ACI Convention

Not Confirmed

GSK

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Switzerland

Mepolizumabum

Brand Name : Nucala

Dosage Form : Inj L?s

Dosage Strength : 100mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

GSK

2024 ACI Convention

Not Confirmed

GSK

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Switzerland

Mepolizumabum

Brand Name : Nucala

Dosage Form : Inj L?s

Dosage Strength : 100mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

GSK

2024 ACI Convention

Not Confirmed

GSK

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

MEPOLIZUMAB

Brand Name : NUCALA

Dosage Form : SOLUTION

Dosage Strength : 100MG/ML

Packaging :

Approval Date :

Application Number : 2492989

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

GSK

2024 ACI Convention

Not Confirmed

GSK

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

MEPOLIZUMAB

Brand Name : NUCALA

Dosage Form : SOLUTION

Dosage Strength : 100MG/ML

Packaging :

Approval Date :

Application Number : 2492997

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

GSK

2024 ACI Convention

Not Confirmed

GSK

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

MEPOLIZUMAB

Brand Name : NUCALA

Dosage Form : SOLUTION

Dosage Strength : 40MG/0.4ML

Packaging :

Approval Date :

Application Number : 2530821

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

GSK

2024 ACI Convention

Not Confirmed

GSK

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

mepolizumab

Brand Name : Nucala

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

11

GSK

2024 ACI Convention

Not Confirmed

GSK

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

mepolizumab

Brand Name : Nucala

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

12

GSK

2024 ACI Convention

Not Confirmed

GSK

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

mepolizumab

Brand Name : Nucala

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

13

GSK

2024 ACI Convention

Not Confirmed

GSK

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

mepolizumab

Brand Name : Nucala

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

14

GSK

2024 ACI Convention

Not Confirmed

GSK

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

mepolizumab

Brand Name : Nucala

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

15

GSK

2024 ACI Convention

Not Confirmed

GSK

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

mepolizumab

Brand Name : Nucala

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

16

GSK

2024 ACI Convention

Not Confirmed

GSK

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

mepolizumab

Brand Name : Nucala

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

17

GSK

2024 ACI Convention

Not Confirmed

GSK

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

mepolizumab

Brand Name : Nucala

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

18

GlaxoSmithKline Trading

Country

2024 ACI Convention

Not Confirmed

GlaxoSmithKline Trading

Country

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

Regulatory Info :

Registration Country : Sweden

mepolizumab

Brand Name : Nucala

Dosage Form : POWDER FOR SOLUTION FOR INJECTION

Dosage Strength : 100 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?